Loading insider details...
Beta
Latest Form 4 (Oct 14, 2026): Exercise/Conversion of 9,196 RLYB shares, $69.9K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 14, 2026 | Rallybio Corp (RLYB) | Exercise/Conversion | 9,196 | $69.9K |
| Dec 22, 2025 | Evommune, Inc. (EVMN) | Purchase | 1,000 | $17.4K |
| Nov 12, 2025 | Evommune, Inc. (EVMN) | Conversion | 3,026 | n/a |
| May 15, 2025 | Rallybio Corp (RLYB) | Grant/Award | 28,500 | n/a |
| Jan 6, 2025 | Rallybio Corp (RLYB) | Grant/Award | 73,571 | $51.5K |
| Jun 20, 2024 | Inozyme Pharma, Inc. (INZY) | Grant/Award | 28,000 | n/a |
| May 17, 2024 | Rallybio Corp (RLYB) | Grant/Award | 16,500 | n/a |
| May 19, 2023 | Rallybio Corp (RLYB) | Grant/Award | 15,490 | n/a |
| May 27, 2022 | Rallybio Corp (RLYB) | Grant/Award | 13,440 | n/a |
| Jan 6, 2022 | Rallybio Corp (RLYB) | Grant/Award | 6,242 | n/a |